Skip to main content
. 2013 Jan 11;5(2):294–308. doi: 10.1002/emmm.201201869

Figure 4. Hepatic TSC22D4 deficiency promotes hypertriglyceridemia.

Figure 4

  1. Western blot of liver extracts from representative control or TSC22D4 shRNA adenovirus–injected C57Bl/6 mice 7 days after injection using TSC22D4 and VCP antibodies.
  2. Liver TG levels of random fed, 16 h fasted and 6 h refed control or TSC22D4 shRNA adenovirus–injected C57Bl/6 mice 7 days after injection (means ± SEM, n ≥ 6).
  3. Total serum TG levels of the same mice as in B.
  4. Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in random fed control or TSC22D4 shRNA adenovirus-injected C57Bl/6 mice 7 days after injection (means ± SEM, n ≥ 6). Statistical test B, C: Two Way ANOVA; Holm–Sidak post hoc.